{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:10:38Z","timestamp":1791360638197,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.hrthm.2020.08.013","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:38:12Z","timestamp":1598305092000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring"],"prefix":"10.1016","volume":"18","author":[{"given":"Peter A.","family":"Bleszynski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genaro","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bruckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Cove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet K.","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.08.013_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.013_bib2","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.013_bib3","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the ACC\/AHA Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.013_bib4","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the ESC","volume":"35","author":"Zamorano","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.08.013_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.107.738740","article-title":"Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"118","author":"Sorajja","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.08.013_bib6","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1038\/s41598-017-10144-0","article-title":"Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China","volume":"7","author":"An","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2020.08.013_bib7","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jacc.2011.06.073","article-title":"Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter north american registry","volume":"58","author":"Nagueh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2006.07.179","article-title":"Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances","volume":"119","author":"Faber","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1136\/heartjnl-2014-305593","article-title":"Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy","volume":"100","author":"Balt","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2020.08.013_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/hrt.80.3.257","article-title":"Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy","volume":"80","author":"Kazmierczak","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2020.08.013_bib11","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.hlc.2017.09.014","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a 16-year Australian single centre experience","volume":"27","author":"Nogic","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrthm.2020.08.013_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/anec.12335","article-title":"Incidence of atrial fibrillation following alcohol septal ablation for hypertrophic cardiomyopathy","volume":"21","author":"Moss","year":"2016","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/joic.12178","article-title":"Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy","volume":"28","author":"Schuller","year":"2015","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib14","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2007.02.056","article-title":"Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Lawrenz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0735-1097(03)00623-5","article-title":"Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy","volume":"42","author":"Chang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0735-1097(00)00767-1","article-title":"Hypertrophic cardiomyopathy nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up","volume":"36","author":"Lakkis","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/157340308785160561","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"4","author":"Masry","year":"2008","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.hrthm.2020.08.013_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1540-8183.2006.00153.x","article-title":"Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies","volume":"19","author":"Alam","year":"2006","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.hrthm.2020.08.013_bib20","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4022\/jafib.1556","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: diagnosis and considerations for management","volume":"10","author":"Patten","year":"2018","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.hrthm.2020.08.013_bib21","first-page":"25","article-title":"Hypertrophic cardiomyopathy: sudden cardiac death risk stratification in adults","volume":"2018","author":"Jord\u00e0","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.hrthm.2020.08.013_bib22","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.08.013_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjcard.2009.02.056","article-title":"Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"104","author":"Noseworthy","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jchf.2014.07.008","article-title":"Revisiting arrhythmic risk after alcoholseptal ablation: is the pendulum finally swinging\u2026Back to myectomy?","volume":"2","author":"Maron","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2020.08.013_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/eurheartj\/ehr013","article-title":"Hypertrophic obstructive cardiomyopathy: alcohol septal ablation","volume":"32","author":"Fifer","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.08.013_bib27","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jacc.2018.10.044","article-title":"2018 ACC\/AHA\/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the ACC\/AHA Task Force on Clinical Practice Guidelines and the HRS","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.08.013_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIRCHEARTFAILURE.109.862359","article-title":"Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution","volume":"3","author":"Ten Cate","year":"2010","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.hrthm.2020.08.013_bib29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/eurheartj\/ehv693","article-title":"Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Results from the Euro-ASA registry","volume":"37","author":"Veselka","year":"2016","journal-title":"Eur Heart J."}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120308493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120308493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:53:27Z","timestamp":1761548007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120308493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1547527120308493"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.08.013","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}